• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型袢利尿剂托拉塞米在肾功能不全患者体内的消除动力学研究。

Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.

作者信息

Dodion L, Willems J L

出版信息

Eur J Clin Pharmacol. 1986;31 Suppl:49-51. doi: 10.1007/BF00541467.

DOI:10.1007/BF00541467
PMID:3780839
Abstract

The plasma concentration of torasemide was determined as a function of time in 8 patients with impaired renal function (creatinine clearance less than or equal to 25 ml/min). The elimination half-life (1.3 to 3.8 h), the volume of distribution (0.12 to 0.29 l/kg), and the total body clearance (0.02 to 0.10 l/kg X h) were similar to those observed in normal volunteers.

摘要

在8名肾功能受损(肌酐清除率小于或等于25 ml/min)的患者中,测定了托拉塞米的血浆浓度随时间的变化情况。消除半衰期(1.3至3.8小时)、分布容积(0.12至0.29 l/kg)和全身清除率(0.02至0.10 l/kg×小时)与正常志愿者中观察到的情况相似。

相似文献

1
Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.新型袢利尿剂托拉塞米在肾功能不全患者体内的消除动力学研究。
Eur J Clin Pharmacol. 1986;31 Suppl:49-51. doi: 10.1007/BF00541467.
2
Pharmacokinetics of torasemide and its metabolites in end-stage renal disease.托拉塞米及其代谢产物在终末期肾病中的药代动力学
Eur J Clin Pharmacol. 1994;47(2):157-9. doi: 10.1007/BF00194966.
3
Pharmacokinetics and metabolism of torasemide in man.托拉塞米在人体中的药代动力学与代谢
Arzneimittelforschung. 1988 Jan;38(1A):164-6.
4
A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.两种袢利尿剂托拉塞米和呋塞米在正常志愿者体内的药代动力学及利尿效果比较。
Eur J Clin Pharmacol. 1986;31 Suppl:21-7. doi: 10.1007/BF00541463.
5
Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.托拉塞米在人体中的药代动力学研究:其利尿作用概述
Int J Clin Pharmacol Ther Toxicol. 1982 Aug;20(8):382-7.
6
Pharmacokinetics and pharmacodynamics of torasemide in health and disease.托拉塞米在健康与疾病状态下的药代动力学和药效学
J Cardiovasc Pharmacol. 1993;22 Suppl 3:S24-31. doi: 10.1097/00005344-199322003-00004.
7
The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.血液透析和血液滤过对肾衰竭患者托拉塞米清除率的影响。
Eur J Clin Pharmacol. 1986;31 Suppl:53-5. doi: 10.1007/BF00541468.
8
Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.托拉塞米在正常受试者慢性治疗期间的利尿活性、安全性及药代动力学
Eur J Clin Pharmacol. 1986;31 Suppl:1-7. doi: 10.1007/BF00541460.
9
Clinical pharmacokinetics and pharmacodynamics of torasemide.托拉塞米的临床药代动力学与药效学
Clin Pharmacokinet. 1998 Jan;34(1):1-24. doi: 10.2165/00003088-199834010-00001.
10
Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function.替唑米胺在肾功能正常和减退受试者中的利尿作用及药代动力学
Clin Nephrol. 1983 Mar;19(3):124-31.

引用本文的文献

1
Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.电解质浓度和肾素-血管紧张素-醛固酮激活在犬心脏病分期中的作用。
J Vet Intern Med. 2020 Jan;34(1):53-64. doi: 10.1111/jvim.15662. Epub 2019 Nov 26.
2
The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.血液透析和血液滤过对肾衰竭患者托拉塞米清除率的影响。
Eur J Clin Pharmacol. 1986;31 Suppl:53-5. doi: 10.1007/BF00541468.
3
Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

本文引用的文献

1
Disposition and pharmacodynamics of diuretics and antihypertensive agents in renal disease.肾病中利尿剂和抗高血压药物的处置及药效学
Eur J Clin Pharmacol. 1980 Jul;18(1):109-16. doi: 10.1007/BF00561487.
2
Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.托拉塞米在人体中的药代动力学研究:其利尿作用概述
Int J Clin Pharmacol Ther Toxicol. 1982 Aug;20(8):382-7.
3
Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.呋塞米在肾功能受损患者中的药代动力学和药效学效应。
托拉塞米及其代谢产物在健康对照者和慢性肾衰竭患者中的药代动力学
Eur J Clin Pharmacol. 1990;39(4):345-8. doi: 10.1007/BF00315407.
4
Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.袢利尿剂托拉塞米在慢性肾衰竭中的利钠作用。电解质排泄的相互依赖性。
Eur J Clin Pharmacol. 1990;39(4):337-43. doi: 10.1007/BF00315406.
5
The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.利尿剂在急性和慢性肾衰竭中的疗效。重点关注托拉塞米。
Drugs. 1991;41 Suppl 3:69-79. doi: 10.2165/00003495-199100413-00008.
6
The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.慢性肾衰竭中襻利尿剂托拉塞米的药代动力学和药效学
Drugs. 1991;41 Suppl 3:23-34. doi: 10.2165/00003495-199100413-00005.
7
Torasemide. A review of its pharmacological properties and therapeutic potential.托拉塞米:其药理特性与治疗潜力综述
Drugs. 1991 Jan;41(1):81-103. doi: 10.2165/00003495-199141010-00008.
Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):481-6.
4
Pharmacological properties of the new potent diuretic torasemide in rats and dogs.新型强效利尿剂托拉塞米在大鼠和犬体内的药理特性
Arzneimittelforschung. 1985;35(10):1520-6.
5
ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.ESTRIP,一个用于获取初始多指数参数估计值的BASIC计算机程序。
J Pharm Sci. 1978 Dec;67(12):1687-91. doi: 10.1002/jps.2600671214.
6
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
J Pharmacokinet Biopharm. 1979 Feb;7(1):1-27. doi: 10.1007/BF01059438.